Literature DB >> 8645375

A novel single base deletion in the LDLR gene (211delG): Effect on serum lipid profiles and the influence of other genetic polymorphisms in the ACE, APOE and APOB genes.

A J Ward1, M O'Kane, D P Nicholls, I S Young, N C Nevin, C A Graham.   

Abstract

A single base deletion (211delG) in the low density lipoprotein receptor (LDLR) gene was shown to cause familial hypercholesterolaemia (FH) in a large family from Northern Ireland. Twenty-four of 52 family members tested had this mutation, 13 of which were newly diagnosed. Mutation-positive individuals had significantly higher mean total-cholesterol (TC) and LDL-cholesterol (LDL-C) than those without 211delG. LDL-C was a more accurate indicator of disease status than TC. When TC levels alone were considered, in individuals over 16 years, a false negative rate (TC < 7.5 mmol/l) of 40% was found; however this fell to 13% based on inclusion of LDL-C levels. Individuals with coronary artery disease (CAD) had significantly higher TC levels than those without CAD and tended to have tendinous xanthomas (TX) and corneal arcus (CA). Generic polymorphisms in the angiotensin converting enzyme (ACE) and apolipoprotein (apo) B genes did not appear to be associated with lipid levels or with the clinical severity of the disease; however, the apo E epsilon4 allele did show a lipid-raising effect in individuals with the mutation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645375     DOI: 10.1016/0021-9150(95)05685-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Screening for familial hypercholesterolaemia. Funding is difficult to obtain but screening can be international.

Authors:  B Tomlinson; I W Lan; I Hamilton-Craig
Journal:  BMJ       Date:  2001-04-28

2.  Software and database for the analysis of mutations in the human LDL receptor gene.

Authors:  M Varret; J P Rabès; G Collod-Béroud; C Junien; C Boileau; C Béroud
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

3.  Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.

Authors:  R Durst; R Colombo; S Shpitzen; L B Avi; Y Friedlander; R Wexler; F J Raal; D A Marais; J C Defesche; M Y Mandelshtam; M J Kotze; E Leitersdorf; V Meiner
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

4.  Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing.

Authors:  Steve E Humphries; Treena Cranston; Marcus Allen; Helen Middleton-Price; Maryam C Fernandez; Victoria Senior; Emma Hawe; Andrew Iversen; Richard Wray; Martin A Crook; Anthony S Wierzbicki
Journal:  J Mol Med (Berl)       Date:  2005-12-31       Impact factor: 4.599

5.  Diagnosis of families with familial hypercholesterolaemia and/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations.

Authors:  K Widhalm; A Dirisamer; A Lindemayr; G Kostner
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.